Report Code : CVMI2412215 | Published Date : March 3, 2025

The Global Adrenoleukodystrophy (ALD) market was valued at USD 489.9 million in 2023 and is projected to reach USD 1.29 billion by 2031, growing at a CAGR of 14.9%. ALD is a rare X-linked metabolic disorder affecting 1 in 17,000 newborns, causing progressive neurological deterioration and adrenal insufficiency. Increased newborn screening, gene therapy advancements, and orphan drug designations drive the market growth.

Key Market Drivers

  1. Newborn Screening Expansion
    • 38 U.S. states now mandate ALD screening (up from 5 in 2018)
    • EU's Screen4Rare initiative aims for pan-European screening by 2026
  2. Gene Therapy Breakthroughs
    • Bluebird Bio's Skysona® (elivaldogene autotemcel) approved in 2022
    • 90% survival rate in early-intervention cerebral ALD cases
  3. Orphan Drug Incentives
    • 7-year market exclusivity in U.S. and EU
    • FDA's RMAT designation for 3 pipeline therapies
  4. Patient Advocacy Growth
    • ALD Alliance funding increased 300% since 2020
    • Global registry now tracks 5,000+ patients

 

Market Segmentation

By Treatment Type

  • Hematopoietic Stem Cell Transplant (HSCT) (45%): Gold standard for cerebral ALD
  • Lorenzo's Oil (XX%): Dietary therapy slowing progression
  • Adrenal Replacement (XX%): Cortisol management
  • Gene Therapy (XX%): Emerging curative approach
  • Others (XX%): Supportive therapies

By Disease Type

  • Childhood Cerebral ALD (XX%): Most aggressive form
  • Adrenomyeloneuropathy (XX%): Adult-onset variant
  • Addison-Only (10%): Adrenal involvement without neurological symptoms

 

Regional Analysis

  • North America (50% market share): Advanced screening and treatment centers
  • Europe (XX%): Strong socialized medicine coverage
  • Asia-Pacific (XX%): Improving diagnosis rates
  • Rest of World (XX%): Limited treatment access

 

Competitive Landscape

Key Players:

  1. Bluebird Bio (Gene Therapy)
  2. Minoryx Therapeutics (Leriglitazone)
  3. SwanBio Therapeutics (AAV9 Gene Therapy)
  4. Applied Genetic Technologies (AGTC-401)
  5. NeuroVia (NV1205)

 

Recent Developments

  • 2024: FDA approval for SwanBio's SB-001 intrathecal gene therapy
  • 2023: EU approval for Minoryx's leriglitazone
  • 2022: NIH $25M grant for newborn screening expansion




Reasons To Buy

Image



Scope

Image

Key Players

  • Bluebird Bio
  • Minoryx Therapeutics
  • Nutricia
  • Poxel SA
  • Orpheris Inc.
  • MedDay Pharmaceuticals
  • Takeda Pharmaceutical Company
  • SwanBio Therapeutics
  • Passage Bio
  • Applied Genetic Technologies Corporation.

 

Global Adrenoleukodystrophy Market Report

  1. 1. Global Adrenoleukodystrophy Market Research Report
    1. 1.1 Study Objectives
    2. 1.2 Global Adrenoleukodystrophy Market - Overview
    3. 1.3 Reason to Read This Report
    4. 1.4 Methodology and Forecast Analysis
    2. Global Adrenoleukodystrophy Market Research Report - Preface
    1. 2.1 Global Adrenoleukodystrophy Market Research Report – Detailed Scope and Definitions
      1. 2.1.1 By Treatment
      2. 2.1.2 By End-user
      3. 2.1.3 By Region
    3. Global Adrenoleukodystrophy Market Dynamics
    1. 3.1. Drivers - Macro-Economic Based, Supply Side, and Demand Side Drivers
    2. 3.2. Restraints – By Treatment, By End-user, By Country
    3. 3.3. Opportunities – By Treatment, By End-user, By Country
    4. 3.4. Trends – By Treatment, By End-user, By Country
    5. 3.5. PEST Analysis
    6. 3.6. Porters Five Rule Analysis
    7. 3.7. Company’s Share Analysis (CSA) by Region or By Country
    8. 3.8. Global Adrenoleukodystrophy Market Research Report – DROTs Impact Analysis
    4. Global Adrenoleukodystrophy Market Research Report, Historic Data 2019 - 2023 and Forecast Analysis Data 2024 - 2031
    1. 4.1. Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
    2. 4.2. Annual Market Trend Assessment – Year-on-Year (YoY) Growth Analysis (%)
    3. 4.3. Incremental Market Value/Volume Opportunity between 2019 - 2023 and 2024 - 2031
    4. 4.4. Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
    5. Global Adrenoleukodystrophy Market, By Treatment, 2019 - 2023 and Forecast, 2024 - 2031 (Market Value, In USD Mn)
    1. 5.1 Corticosteroids
      1. 5.1.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
      2. 5.1.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
      3. 5.1.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
      4. 5.1.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
    2. 5.2 Gene Therapy
      1. 5.2.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
      2. 5.2.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
      3. 5.2.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
      4. 5.2.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
    3. 5.3 Bone Marrow Transplant
      1. 5.3.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
      2. 5.3.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
      3. 5.3.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
      4. 5.3.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
    4. 5.4 Others
      1. 5.4.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
      2. 5.4.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
      3. 5.4.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
      4. 5.4.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
    6. Global Adrenoleukodystrophy Market, By End-user, 2019 - 2023 and Forecast, 2024 - 2031 (Market Value, In USD Mn)
    1. 6.1 Hospitals
      1. 6.1.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
      2. 6.1.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
      3. 6.1.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
      4. 6.1.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
    2. 6.2 Specialty Clinics
      1. 6.2.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
      2. 6.2.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
      3. 6.2.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
      4. 6.2.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
    3. 6.3 Research Institutes.
      1. 6.3.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
      2. 6.3.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
      3. 6.3.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
      4. 6.3.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
    7. Global Adrenoleukodystrophy Market Forecast, By Region, 2019 - 2023 and 2024 - 2031 (Market Value, In USD Mn)
    1. 7.1 North America
      1. 7.1.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
      2. 7.1.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
      3. 7.1.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
      4. 7.1.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
    2. 7.2 Europe
      1. 7.2.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
      2. 7.2.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
      3. 7.2.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
      4. 7.2.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
    3. 7.3 Asia-Pacific
      1. 7.3.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
      2. 7.3.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
      3. 7.3.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
      4. 7.3.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
    4. 7.4 Latin America
      1. 7.4.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
      2. 7.4.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
      3. 7.4.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
      4. 7.4.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
    5. 7.5 Middle East & Africa
      1. 7.5.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
      2. 7.5.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
      3. 7.5.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
      4. 7.5.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
    6. 7.6 Global Adrenoleukodystrophy Market - Opportunity Analysis Index, By Treatment, By End-user, and Region, 2024 - 2031
    8. North America Global Adrenoleukodystrophy Market Analysis, 2019 - 2023 and Forecast, 2024 - 2031 (Market Value, In USD Mn)
    1. 8.1 By Treatment Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
      1. 8.1.1 Corticosteroids
      2. 8.1.2 Gene Therapy
      3. 8.1.3 Bone Marrow Transplant
      4. 8.1.4 Others
      8.2 By End-user Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
      1. 8.2.1 Hospitals
      2. 8.2.2 Specialty Clinics
      3. 8.2.3 Research Institutes.
      8.3 Country Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
      1. 8.3.1 United States
      2. 8.3.2 Canada
      8.4 North America Global Adrenoleukodystrophy Market – Opportunity Analysis Index, By Treatment, By End-user, and Country, 2024 - 2031
      8.5 Regional Trends Analysis
      8.6 North America Global Adrenoleukodystrophy Market Research Report - Company Profiles
      1. 8.6.1 Company 1 (United States)
      2. 8.6.2 Company 2 (Canada)
      3. 8.6.3 Company 3 (Canada)
    9. Europe Global Adrenoleukodystrophy Market Analysis, 2019 - 2023 and Forecast, 2024 - 2031 (Market Value, In USD Mn)
    1. 9.1 By Treatment Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
      1. 9.1.1 Corticosteroids
      2. 9.1.2 Gene Therapy
      3. 9.1.3 Bone Marrow Transplant
      4. 9.1.4 Others
      9.2 By End-user Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
      1. 9.2.1 Hospitals
      2. 9.2.2 Specialty Clinics
      3. 9.2.3 Research Institutes.
      9.3 Country Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
      1. 9.3.1 Germany
      2. 9.3.2 United Kingdom
      3. 9.3.3 France
      4. 9.3.4 Spain
      5. 9.3.5 Italy
      6. 9.3.6 Russia
      7. 9.3.7 Netherlands
      8. 9.3.8 Poland
      9. 9.3.9 Rest of Europe
      9.4 Europe Global Adrenoleukodystrophy Market – Opportunity Analysis Index, By Treatment, By End-user, and Country, 2024 - 2031
      9.5 Regional Trends Analysis
      9.6 Europe Global Adrenoleukodystrophy Market Research Report - Company Profiles
      1. 9.6.1 Company 1 (Germany)
      2. 9.6.2 Company 2 (United Kingdom)
      3. 9.6.3 Company 3 (United Kingdom)
    10. Asia-Pacific Global Adrenoleukodystrophy Market Analysis, 2019 - 2023 and Forecast, 2024 - 2031 (Market Value, In USD Mn)
    1. 10.1 By Treatment Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
      1. 10.1.1 Corticosteroids
      2. 10.1.2 Gene Therapy
      3. 10.1.3 Bone Marrow Transplant
      4. 10.1.4 Others
      10.2 By End-user Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
      1. 10.2.1 Hospitals
      2. 10.2.2 Specialty Clinics
      3. 10.2.3 Research Institutes.
      10.3 Country Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
      1. 10.3.1 China
      2. 10.3.2 Japan
      3. 10.3.3 India
      4. 10.3.4 South Korea
      5. 10.3.5 Australia & NZ
      6. 10.3.6 ASEAN
      7. 10.3.7 Rest of Asia-Pacific
      10.4 Asia-Pacific Global Adrenoleukodystrophy Market – Opportunity Analysis Index, By Treatment, By End-user, and Country, 2024 - 2031
      10.5 Regional Trends Analysis
      10.6 Asia-Pacific Global Adrenoleukodystrophy Market Research Report - Company Profiles
      1. 10.6.1 Company 1 (China)
      2. 10.6.2 Company 2 (Japan)
      3. 10.6.3 Company 3 (Japan)
    11. Latin America Global Adrenoleukodystrophy Market Analysis, 2019 - 2023 and Forecast, 2024 - 2031 (Market Value, In USD Mn)
    1. 11.1 By Treatment Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
      1. 11.1.1 Corticosteroids
      2. 11.1.2 Gene Therapy
      3. 11.1.3 Bone Marrow Transplant
      4. 11.1.4 Others
      11.2 By End-user Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
      1. 11.2.1 Hospitals
      2. 11.2.2 Specialty Clinics
      3. 11.2.3 Research Institutes.
      11.3 Country Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
      1. 11.3.1 Brazil
      2. 11.3.2 Mexico
      3. 11.3.3 Argentina
      4. 11.3.4 Peru
      5. 11.3.5 Colombia
      6. 11.3.6 Rest of Latin America
      11.4 Latin America Global Adrenoleukodystrophy Market – Opportunity Analysis Index, By Treatment, By End-user, and Country, 2024 - 2031
      11.5 Regional Trends Analysis
      11.6 Latin America Global Adrenoleukodystrophy Market Research Report - Company Profiles
      1. 11.6.1 Company 1 (Brazil)
      2. 11.6.2 Company 2 (Mexico)
      3. 11.6.3 Company 3 (Mexico)
    12. Middle East & Africa Global Adrenoleukodystrophy Market Analysis, 2019 - 2023 and Forecast, 2024 - 2031 (Market Value, In USD Mn)
    1. 12.1 By Treatment Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
      1. 12.1.1 Corticosteroids
      2. 12.1.2 Gene Therapy
      3. 12.1.3 Bone Marrow Transplant
      4. 12.1.4 Others
      12.2 By End-user Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
      1. 12.2.1 Hospitals
      2. 12.2.2 Specialty Clinics
      3. 12.2.3 Research Institutes.
      12.3 Country Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
      1. 12.3.1 Saudi Arabia
      2. 12.3.2 UAE
      3. 12.3.3 South Africa
      4. 12.3.4 Egypt
      5. 12.3.5 Israel
      6. 12.3.6 Rest of Middle East and Africa
      12.4 Middle East & Africa Global Adrenoleukodystrophy Market – Opportunity Analysis Index, By Treatment, By End-user, and Country, 2024 - 2031
      12.5 Regional Trends Analysis
      12.6 Middle East & Africa Global Adrenoleukodystrophy Market Research Report - Company Profiles
      1. 12.6.1 Company 1 (Saudi Arabia)
      2. 12.6.2 Company 2 (UAE)
      3. 12.6.3 Company 3 (UAE)
    13. Competition Landscape
    1. 13.1 Strategic Dashboard of Top Market Players
      13.2 Company Profiles (Introduction, Financial Assessments, Portfolio of Offerings, Milestones and Achievements, Strategic Initiative, and SWOT Analysis)
      1. 13.2.1 Bluebird Bio
      2. 13.2.2 Minoryx Therapeutics
      3. 13.2.3 Nutricia
      4. 13.2.4 Poxel SA
      5. 13.2.5 Orpheris Inc.
      6. 13.2.6 MedDay Pharmaceuticals
      7. 13.2.7 Takeda Pharmaceutical Company
      8. 13.2.8 SwanBio Therapeutics
      9. 13.2.9 Passage Bio
      10. 13.2.10 Applied Genetic Technologies Corporation.
    14. Data Collection Method and Research Approach
    15. Principal Presumptions and Acronyms



    2.